Supplements for Eczema: Which Nutrients Have Real Evidence, at What Dose, and What to Skip

Eczema (atopic dermatitis) is stubborn, and the supplement aisle is loud. If you or your child already uses a moisturizer or a prescription cream and still fights flare after flare, you have probably asked whether a pill or an oil could quiet things down. This guide answers that the way a careful clinician would: which nutrients have real human trial evidence, what dose the trials actually used, and where the honest answer is that the science falls apart.

The Honest Bottom Line

Here is the shortest version. No supplement replaces the basics: gentle skin care, a daily moisturizer, and whatever your clinician prescribes. The strongest evidence points to correcting a nutrient deficiency, not to megadosing someone who is already replete.

The Cochrane review that pools this literature reached a blunt conclusion: dietary supplements "cannot be recommended for the public or for clinical practice at present." Most trials were small and underpowered. That does not mean nothing helps, only that the proof is thin and the smart move is to test and target.

Three rules:

• Correct a measured deficiency instead of adding a random supplement.
• Give any product 8 to 12 weeks before you judge it.
• Keep standard skin care going, and treat any supplement as an addition.

Browse our skin and cosmetic care collection for the skin care side.

Which Supplements for Eczema Have Real Evidence

This is the table most pages skip: what the trials found, the dose actually used, and a grade for the strength of the human evidence.

The grades read plainly: a B is real evidence with a caveat, a C is weak or deficiency-only, and a D failed.

Vitamin D: The Split Verdict

Vitamin D is the most asked-about nutrient for eczema, and the most honestly split. Two good sources disagree.

On the positive side, a 2024 meta-analysis pooled 11 randomized trials with 686 participants. Vitamin D supplementation significantly reduced atopic dermatitis severity, with a modest standardized mean difference of -0.41 (95% CI -0.67 to -0.16, I2 = 58%, p < 0.01).

On the negative side, a 2024 randomized trial gave 101 children weekly vitamin D3 for 6 weeks. Blood levels of 25(OH)D rose sharply, so the vitamin was absorbed (+43.4 versus +2.3 nmol/L, p < 0.001). Yet the change in SCORAD, the standard severity score, did not differ from placebo: -5.3 versus -5.5, p = 0.91. There was also no change in eosinophils, total IgE, or S. aureus colonization.

Why the split? Note that 57% of those children were deficient at baseline. Correcting a level that is already fine may do little, while filling a real gap may show up as a small improvement.

The Cochrane pooled data for vitamin D versus placebo stayed flat (SCORAD mean difference 1.00, 95% CI -7.04 to 9.04; topical steroid use -0.31, 95% CI -0.97 to 0.35), though one small trial of vitamin D plus vitamin E reached a SCORAD mean difference of -9.8 (95% CI -17.21 to -2.39).

The honest reading: vitamin D is worth taking if you are low, and it is not a megadose story.

Omega-3 (Fish Oil): A Signal, Not Proof

Fish oil is the supplement people trust most and the evidence supports least clearly.

The Cochrane review pooled three fish oil trials in adults of 31, 145, and 48 people. Participant-rated outcomes improved: total symptom score mean difference 10.00 (95% CI 0.14 to 19.86), effect on daily living -0.84 (95% CI -1.52 to -0.15), area affected -0.59 (95% CI -1.13 to -0.06), and itch -2.50 (95% CI -4.46 to -0.54). But physician-rated measures were not significant, and the largest single trial, Soyland 1994 with 145 people, showed no benefit. The authors call the picture "a possible modest benefit."

The most striking numbers came from children, with a caveat. In 52 children over 4 months, an omega-3 plus GLA plus vitamin D combination was linked to a SCORAD median that fell from 42 to 25 (p < 0.001) and topical steroid use that fell from 30 to 10 mg per month (p < 0.001). Because three nutrients were combined, no single ingredient can take the credit.

Signal, not proof, and probably modest. If you do buy fish oil, form and freshness matter more than the marketing, which we cover in our fish oil buying guide. A concentrated option such as Integrative Therapeutics Pure Omega Ultra HP delivers more EPA and DHA per softgel.

Evening Primrose Oil and Borage Oil: Why This One Failed

This is the one an old magazine told you to take, and it is worth explaining plainly, because three pages ranking for this topic still mention it.

The idea had a moment in the 1980s, when evening primrose oil was marketed as Efamol and GLA, its active fatty acid, was thought to correct a fat-processing problem behind eczema. The mechanism sounded reasonable, but the controlled trials did not agree.

A review of 27 studies, 19 on evening primrose oil and 8 on borage oil, running 3 to 24 weeks, found that neither significantly improved global eczema symptoms versus placebo. Separately, a 2015 review in the Journal of the German Society of Dermatology concluded that GLA supplementation "has proven unsuccessful in the prevention or treatment of atopic dermatitis."

What it means for you: if evening primrose oil seems to help, you are not imagining it, but you are not following the evidence either. The placebo effect in skin conditions is strong. For background on the product, see our evening primrose oil guide.

Probiotics and the Gut-Skin Axis

The gut and the skin talk to each other, and researchers call that link the gut-skin axis. Your gut bacteria shape immune signals that travel through the body, and those signals can influence how reactive the skin is. That is a mechanism, not proof, but it explains why probiotics get studied here.

Two things follow: the community of bacteria matters more than any single strain, and timing matters, because the gut microbiome is most shapeable early in life. That is why prevention studies focus on infants.

The prevention data are the strongest. A 2020 meta-analysis pooled 25 studies: 14 prevention studies with 3,049 children and 11 treatment studies with 816 children. The pooled relative risk of developing atopic dermatitis with probiotics versus placebo in prevention was 0.70 (95% CI 0.57 to 0.84, p = 0.0002). Only mixed strains produced a significant effect, and probiotics given to infants only did not prevent the condition.

The treatment data come from newer trials. In 151 children under 2 with atopic dermatitis and cow's milk protein allergy, more improved (SCORAD down at least 30%) on a three-strain Lactobacillus preparation than on placebo, odds ratio 2.56 (95% CI 1.13 to 5.8, p = 0.012) at 3 months, with benefit held at 9 months. Both groups improved, so the probiotic added to an elimination diet rather than replacing it. The ProPAD trial tested Lacticaseibacillus rhamnosus GG: more children reached the minimum clinically important difference at 12 and 16 weeks, with more rescue-medication-free days, better quality of life, and microbiome changes only in the LGG group.

The Cochrane authors add a caveat: mixtures or Lactobacillus species outperformed Bifidobacterium alone, and single strains did not.

If you try one:

• Choose a multi-strain product.
• Give it 8 to 12 weeks before judging.
• For prevention, start early and continue past one year of age.

A spore-based multi-strain example is Researched Nutritionals CoreBiotic, which pairs three sequenced strains with a prebiotic fiber.

For help picking one, see our guide to how to choose a probiotic, and for the bigger picture, our page on digestion and gut health.

Zinc: Test, Do Not Guess

Zinc is where the gap between "associated with" and "helped by" is widest, and testing beats guessing.

People with atopic dermatitis tend to have lower zinc. A systematic review and meta-analysis of 14 observational studies plus 2 randomized trials found serum zinc lower in people with the condition (standardized mean difference 0.66, 95% CI 0.21 to 1.10, p = 0.004), hair zinc lower (SMD 0.95, 95% CI 0.38 to 1.52, p = 0.001), and red blood cell zinc lower (SMD 0.95, 95% CI 0.38 to 1.52, p = 0.001). Every included study was low or moderate quality.

Lower levels do not prove that adding zinc helps. One trial in zinc-deficient patients improved extent and severity, while another in all patients showed no significant improvement. The Cochrane data settled it further: zinc sulphate for 8 weeks in 50 children produced no severity difference, and parent-rated itch was actually worse on zinc at 8 weeks (mean difference 1.20, 95% CI 0.02 to 2.38).

The takeaway: if you suspect low zinc, test your level rather than guessing, and never treat a normal level as a deficiency. If a clinician finds you are low, correcting it supports normal skin function. Supplementing when you are replete has not been shown to help, and one trial looked worse. For the full picture, read our zinc and copper skincare guide.

What Does Not Work for Eczema

Naming the failures is as useful as naming the wins.

• Vitamin B6 (pyridoxine): no difference in parent-rated symptoms (RR 1.05, 95% CI 0.83 to 1.33).
• Selenium, alone or with vitamin E: no meaningful differences.
• Vitamin E alone: no SCORAD benefit (mean difference -1.90, 95% CI -9.43 to 5.63); only lichenification and dryness improved.
• Sea buckthorn seed and pulp oils: no SCORAD differences.
• Hempseed oil: a 20-adult crossover showed within-group improvements in dryness (p = 0.027) and itchiness (p = 0.023), but with no placebo arm, no between-group claim is possible.
• Chinese herbal medicine: a Cochrane review of 28 randomized trials found no conclusive evidence of benefit, on very low quality evidence.

Treat that list as a fair starting point for expectations, not a reason to ignore a measured deficiency.

How to Read an Eczema Supplement Label

If you try something, read the label the way a researcher reads a trial. The form, the dose, and the strain decide whether what you buy resembles what was studied.

• Match the form to the evidence. Look for vitamin D3 rather than a vague "vitamin D," and marine triglyceride oil for omega-3.
• Find the strain, not just the word probiotic. A credible label names each genus, species, and strain, and states CFU counts.
• Check the serving size. A number on the front often applies to two or more capsules.
• Prefer third-party testing. Independent verification supports purity and label accuracy.
• Skip megadoses. The trials used modest, targeted amounts, not the biggest number on the shelf.

A supplement that supports skin barrier function and a healthy inflammatory response does so best when it matches a real need. For a wider view, see our nutrients for healthy skin guide.

Safety and Who Should Not Take These

Supplements are not automatically safe because they are natural. Here is what to watch.

• Fat-soluble vitamins accumulate. Vitamin D and vitamin E are stored in the body, so high doses can become toxic. The Cochrane authors note that high-dose vitamin D can cause serious medical problems.
• Evening primrose oil may slow blood clotting. Take care if you use aspirin or other anti-inflammatory medicines.
• Large amounts of oil can upset your stomach. Excessive oil intake caused diarrhea, nausea, and stomach upset in trials.
• Probiotics are not risk-free for everyone. In some populations, including people with Crohn's disease, they can worsen things.
• Check with a clinician first if you are pregnant, breastfeeding, on blood thinners, or managing a chronic condition.

Think of any supplement as an addition to standard care, never a swap for it.

What We Recommend

None of these is a proven stand-alone eczema treatment. Each is chosen to support nutrition and skin barrier needs while the standard care your clinician recommends continues.

Frequently Asked Questions

References

1. Nielsen AY, Hoj S, Thomsen SF, et al. Vitamin D Supplementation for Treating Atopic Dermatitis in Children and Adults: A Systematic Review and Meta-Analysis. Nutrients. 2024;16(23):4128. https://pubmed.ncbi.nlm.nih.gov/39683522/
2. Borzutzky A, Iturriaga C, Perez-Mateluna G, et al. Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2024;38(9):1760-1768. https://pubmed.ncbi.nlm.nih.gov/38483248/
3. Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev. 2012;(2):CD005205. https://pubmed.ncbi.nlm.nih.gov/22336810/
4. Niseteo T, Hojsak I, Ozanic Bulic S, Pustisek N. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children. Nutrients. 2024;16(17):2829. https://pubmed.ncbi.nlm.nih.gov/39275147/
5. Diet and eczema: a review of dietary supplements for the treatment of atopic dermatitis. PMC5006549. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006549/
6. Reese I, Werfel T. Do long-chain omega-3 fatty acids protect from atopic dermatitis? J Dtsch Dermatol Ges. 2015;13(9):879-885. https://pubmed.ncbi.nlm.nih.gov/26882378/
7. Jiang W, Ni B, Liu Z, et al. The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Paediatr Drugs. 2020;22(5):535-549. https://pubmed.ncbi.nlm.nih.gov/32748341/
8. Cukrowska B, Ceregra A, Maciorkowska E, et al. The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow's Milk Protein Allergy. Nutrients. 2021;13(4):1169. https://pubmed.ncbi.nlm.nih.gov/33916192/
9. Carucci L, Nocerino R, Paparo L, et al. Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial. Pediatr Allergy Immunol. 2022;33(8):e13836. https://pubmed.ncbi.nlm.nih.gov/36003050/
10. Mahmud MR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes. 2022;14(1):2096995. https://pubmed.ncbi.nlm.nih.gov/35866234/
11. Rios-Carlos M, Cervantes-Garcia D, Cordova-Davalos LE, et al. Unraveling the gut-skin axis in atopic dermatitis. Gut Microbes. 2024;16(1):2430420. https://pubmed.ncbi.nlm.nih.gov/39601281/
12. Mohammad S, Karim MR, Iqbal S, et al. Atopic dermatitis: Pathophysiology, microbiota, and metabolome, a comprehensive review. Microbiol Res. 2024;281:127595. https://pubmed.ncbi.nlm.nih.gov/38218095/
13. Gray NA, Dhana A, Stein DJ, Khumalo NP. Zinc and atopic dermatitis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(6):1042-1050. https://pubmed.ncbi.nlm.nih.gov/30801794/
14. Williams HC, Chalmers J. Prevention of Atopic Dermatitis. Acta Derm Venereol. 2020;100(12):adv00166. https://pubmed.ncbi.nlm.nih.gov/32419030/
15. Bayles B, Usatine R. Evening primrose oil. Am Fam Physician. 2009;80(12):1405-1408. https://pubmed.ncbi.nlm.nih.gov/20000302/

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.